All serum samples that were seropositive for both DENV and ZIKV, or both, were classified as flavivirus-positive. and ZIKV Nonstructural protein 1 (NS 1), DENV and ZIKV Equad (variant of the envelope protein with designated mutations to increase specificity), according to the manufacturers instructions. == Results == The overall IgG antibody seropositivity against DENV-flavivirus was 44.7% (389/871); 95% CI (41.4147.99), while ZIKV-flavivirus was 19.2% (167/871); 95% CI (0.160.21), and DENV-ZIKV-flavivirus cocirculation antibody seropositivity was 6.2%5 (54/871); 95% CI (0.60.7) in the three study regions of Nigeria. The study cohort presented related clinical signs and symptoms of flaviviruses (DENV and ZIKV) in all three study areas. == Summary == This study highlighted an unexpectedly high antibody seropositivity, burden, hidden endemicity, and regional spread of LM22A-4 mono- and co-circulating flaviviruses (DENV and ZIKV) in Nigeria. == Important communications == Dengue flavivirus sero-cross-reactivity drives antibody-dependent enhancement of ZIKV illness. Both viruses share common hosts (humans) and vectors (primarily Aedes aegypti), and are therefore affected by related biological, ecological, and economic factors, resulting in epidemiological synergy. Additionally, the actual burden in epidemic and interepidemic periods is definitely grossly or chronically unfamiliar and underreported. Despite this tendency and the potential general public health threat, you will find no reliable data, and little is known about these arboviral co-circulation infections. Keywords:Endemicity, chikungunya, dengue, Nigeria, seroprevalence, burden == LM22A-4 Background == Individuals living in arbovirus-endemic areas have reported complex arbovirus infections, including concurrent and simultaneous infections with dengue disease (DENV) and Zika disease (ZIKV), [1,2]. There is a high incidence of dengue fever in urban and semiurban environments, and it has spread to tropical areas, becoming one of the causes of death. Southeast Asia and Sub-Saharan Africa LM22A-4 LM22A-4 are the most affected areas, with high temps and poor sanitation [3]. Dengue fever is definitely caused by four serotypes (DENV1-4) of flaviviruses [3]. An important symptom of this disease is definitely fever, which is usually accompanied by severe body pain [3]. Zika virus is an growing arthropod-borne virus belonging to the genus Flavivirus. The 1st human illness in Sub-Saharan Africa occurred in Nigeria in 1954 [4]. The emergence of dengue disease (DENV) and Zika disease (ZIKV) in chikungunya disease (CHIKV)-endemic areas has created intriguing but potentially alarming scenarios [5]. It has been postulated by a study carried out in Sri Lanka that for Zika and dengue viruses, prior illness with one disease modulates the severity of subsequent illness with the additional disease [6]. This poses a major health concern, because of the high homology between LM22A-4 these arboviruses, cross-reactivity of antibodies against flaviviruses such as DENV, ZIKV, yellow fever disease (YFV), tick-borne encephalitis disease (TBEV), and Japanese encephalitis disease (JEV) can occur, which may complicate the interpretation of serological results, coinfection and severe and foetal results. There are several serodiagnostic checks for arboviral infections, including the enzyme-linked immunosorbent assay (ELISA), neutralization test (NT), immunofluorescence assay (IFA), and hemagglutination inhibition test. Dengue and Zika infections can be serologically diagnosed most reliably and specifically using PRNT [1,7]. However, PRNT is definitely time consuming and requires a Biosafety Level 3 facility to handle live viruses. Comparatively, ELISA is simple and safe, but it is definitely hindered by cross-reactivity among flaviviruses [1,2,4,5,8,9]. Both viruses share common hosts (humans) and vectors (primarilyAedes aegypti), and are thus affected by similar biological, ecological, and economic factors [1,2,5,7,10], resulting in epidemiological synergy. Additionally, the actual burden in epidemic and interepidemic periods is definitely grossly unfamiliar and underreported [10]. Despite this tendency and the potential general public health threat, you will find no reliable data, and little is known about the co-circulation of these arboviral infections. In the present study, we investigated the seropositivity, geographical spread, burden, and hidden endemicity of DENV and ZIKV, and their possible cocirculation (participants who have been serologically positive for DENV and ZIKV during the sampling period or time) in three regions of Nigeria [1,46,1012]. This will help in the characterization of the epidemiological patterns of these growing viruses. These data will also aid clinicians and policymakers in developing and implementing effective control actions. == Method CR2 == == Study design and site == This cross-sectional study was carried out in three university or college teaching hospitals located in three geographical regions of Nigeria: Nasarawa State.
All serum samples that were seropositive for both DENV and ZIKV, or both, were classified as flavivirus-positive
